WEKO3
アイテム
{"_buckets": {"deposit": "00285946-73f1-4434-85e4-4878cf65d97f"}, "_deposit": {"created_by": 1, "id": "70227", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "70227"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00070227", "sets": ["28"]}, "author_link": ["689551", "689552", "689545", "689549", "689542", "689541", "689544", "689540", "689548", "689550", "689543", "689546", "689553", "689547"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2010-09-11", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The catecholamine, dopamine (DA), is synthesized from 3,4-dihydroxy-L-phenylalanine (L-DOPA) by aromatic L-amino acid decarboxylase (AADC). DA metabolism is regulated by monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT). To measure dopaminergic metabolism, we used microdialysis with radiometric detection to monitor L-[beta-11C]DOPA metabolites in the extracellular space of the rat striatum and plasma. We also evaluated the effects of AADC, MAO, and COMT inhibitors on striatal metabolite profiles. \nL-[beta-11C]DOPA and its radioactive metabolites, [11C]3,4-dihydroxyphenylacetic acid ([11C]DOPAC), [11C]homovanillic acid ([11C]HVA), L-3-O-methyl-[11C]DOPA ([11C]3-OMD) and [11C]3-methoxytyramine ([11C]3-MT) were detected, however [11C]DA was not detected in striatal dialysate following intravenous injection of L-[beta-11C]DOPA. The major early species measured after administration of L-[beta-11C]DOPA were [11C]DOPAC and [11C]HVA in a 1:1 ratio, which shifted toward [11C]HVA with time. An AADC inhibitor increased the uptake of L-[beta-11C]DOPA and [11C]3-OMD and delayed the accumulation of [11C]DOPAC and [11C]HVA. With MAO inhibition, about 80% of total radioactivity was derived from [11C]3-MT. The COMT inhibitor increased [11C]DOPAC and decreased [11C]HVA. L-[beta-11C]DOPA and [11C]3-OMD were detected and then achieved equilibrium in plasma with AADC inhibitor. On the other hand, [11C]3-OMD levels in striatal dialysate decreased significantly following intrastriatal administration of L-[beta-11C]DOPA. These results suggest that [11C]3-OMD in striatal dialysate was generated mostly in peripheral tissue and penetrate into brain. \nOur results reflect the complicated L-DOPA metabolic pathway, suggesting that this method could improve the understanding of the information obtained from an L-[beta-11C]DOPA PET study or provide an index of dopaminergic metabolism-related neuropsychiatric disorders and evaluation of drug therapies for treatment of the disorder.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "2010 World Molecular Imaging Congress", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Okada, Maki"}], "nameIdentifiers": [{"nameIdentifier": "689540", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakao, Ryuji"}], "nameIdentifiers": [{"nameIdentifier": "689541", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hosoi, Rie"}], "nameIdentifiers": [{"nameIdentifier": "689542", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Zhang, Ming-Rong"}], "nameIdentifiers": [{"nameIdentifier": "689543", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Fukumura, Toshimitsu"}], "nameIdentifiers": [{"nameIdentifier": "689544", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Suzuki, Kazutoshi"}], "nameIdentifiers": [{"nameIdentifier": "689545", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Inoue, Osamu"}], "nameIdentifiers": [{"nameIdentifier": "689546", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "岡田 真希", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "689547", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "中尾 隆士", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "689548", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "細井 理恵", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "689549", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "張 明栄", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "689550", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "福村 利光", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "689551", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鈴木 和年", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "689552", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "井上 修", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "689553", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Microdialysis with radiometric monitoring of L-[beta-11C]DOPA metabolites in rat striatum and plasma", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Microdialysis with radiometric monitoring of L-[beta-11C]DOPA metabolites in rat striatum and plasma"}]}, "item_type_id": "10005", "owner": "1", "path": ["28"], "permalink_uri": "https://repo.qst.go.jp/records/70227", "pubdate": {"attribute_name": "公開日", "attribute_value": "2010-09-13"}, "publish_date": "2010-09-13", "publish_status": "0", "recid": "70227", "relation": {}, "relation_version_is_last": true, "title": ["Microdialysis with radiometric monitoring of L-[beta-11C]DOPA metabolites in rat striatum and plasma"], "weko_shared_id": -1}
Microdialysis with radiometric monitoring of L-[beta-11C]DOPA metabolites in rat striatum and plasma
https://repo.qst.go.jp/records/70227
https://repo.qst.go.jp/records/70227b51dbf80-9cb4-4b2a-aa1c-a4f1363d84d5
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2010-09-13 | |||||
タイトル | ||||||
タイトル | Microdialysis with radiometric monitoring of L-[beta-11C]DOPA metabolites in rat striatum and plasma | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Okada, Maki
× Okada, Maki× Nakao, Ryuji× Hosoi, Rie× Zhang, Ming-Rong× Fukumura, Toshimitsu× Suzuki, Kazutoshi× Inoue, Osamu× 岡田 真希× 中尾 隆士× 細井 理恵× 張 明栄× 福村 利光× 鈴木 和年× 井上 修 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The catecholamine, dopamine (DA), is synthesized from 3,4-dihydroxy-L-phenylalanine (L-DOPA) by aromatic L-amino acid decarboxylase (AADC). DA metabolism is regulated by monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT). To measure dopaminergic metabolism, we used microdialysis with radiometric detection to monitor L-[beta-11C]DOPA metabolites in the extracellular space of the rat striatum and plasma. We also evaluated the effects of AADC, MAO, and COMT inhibitors on striatal metabolite profiles. L-[beta-11C]DOPA and its radioactive metabolites, [11C]3,4-dihydroxyphenylacetic acid ([11C]DOPAC), [11C]homovanillic acid ([11C]HVA), L-3-O-methyl-[11C]DOPA ([11C]3-OMD) and [11C]3-methoxytyramine ([11C]3-MT) were detected, however [11C]DA was not detected in striatal dialysate following intravenous injection of L-[beta-11C]DOPA. The major early species measured after administration of L-[beta-11C]DOPA were [11C]DOPAC and [11C]HVA in a 1:1 ratio, which shifted toward [11C]HVA with time. An AADC inhibitor increased the uptake of L-[beta-11C]DOPA and [11C]3-OMD and delayed the accumulation of [11C]DOPAC and [11C]HVA. With MAO inhibition, about 80% of total radioactivity was derived from [11C]3-MT. The COMT inhibitor increased [11C]DOPAC and decreased [11C]HVA. L-[beta-11C]DOPA and [11C]3-OMD were detected and then achieved equilibrium in plasma with AADC inhibitor. On the other hand, [11C]3-OMD levels in striatal dialysate decreased significantly following intrastriatal administration of L-[beta-11C]DOPA. These results suggest that [11C]3-OMD in striatal dialysate was generated mostly in peripheral tissue and penetrate into brain. Our results reflect the complicated L-DOPA metabolic pathway, suggesting that this method could improve the understanding of the information obtained from an L-[beta-11C]DOPA PET study or provide an index of dopaminergic metabolism-related neuropsychiatric disorders and evaluation of drug therapies for treatment of the disorder. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 2010 World Molecular Imaging Congress | |||||
発表年月日 | ||||||
日付 | 2010-09-11 | |||||
日付タイプ | Issued |